Free Trial

Rapport Therapeutics (RAPP) SEC Filings & 10K Form

Rapport Therapeutics logo
$14.60 -0.78 (-5.07%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$14.60 0.00 (-0.03%)
As of 07/11/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Rapport Therapeutics SEC Filings

DateFilerForm TypeView
07/09/2025
11:15 PM
Rapport Therapeutics (Filer)
Form EFFECT
07/09/2025
11:15 PM
Rapport Therapeutics (Filer)
Form EFFECT
07/01/2025
5:55 AM
Rapport Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/01/2025
5:51 AM
Rapport Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/18/2025
3:30 PM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
3:15 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
PAUL STEVEN M (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Huber Reid M (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
HEALY JAMES (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
MARAGANORE JOHN (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:24 PM
Bredt David (Reporting)
Rapport Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
6:15 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:30 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
5:07 AM
Rapport Therapeutics (Filer)
Form DEF 14A
04/24/2025
5:08 AM
Rapport Therapeutics (Filer)
Form DEFA14A
04/24/2025
5:10 AM
Rapport Therapeutics (Filer)
Form ARS
04/16/2025
4:00 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:00 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:20 PM
Bredt David (Reporting)
Rapport Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
4:13 PM
Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:45 AM
Rapport Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2025
6:30 AM
Rapport Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
6:15 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:14 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:15 PM
Rapport Therapeutics (Subject)
Third Rock Ventures V, L.P. (Filed by)
Form SCHEDULE 13G
02/04/2025
4:30 PM
Gault Cheryl (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Ceesay Abraham (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Bredt David (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Rapport Therapeutics (Issuer)
Yeleswaram Krishnaswamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Ignelzi Troy A. (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:30 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:11 PM
Cormorant Asset Management, LP (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G/A
11/13/2024
11:26 AM
Capital International Investors (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
11/12/2024
9:34 AM
FMR LLC (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G/A
11/07/2024
5:59 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:00 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:00 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.

This little-known company holds nearly 100 patents and trades for around $7
11/07/2024
5:35 PM
Rapport Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:45 PM
PEREZ ROBERT J (Reporting)
Rapport Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:47 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
5:27 PM
Rapport Therapeutics (Issuer)
Young Wendy B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
5:31 PM
Rapport Therapeutics (Issuer)
Sanchez Ramiro (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2024
6:30 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
4:23 PM
JOHNSON & JOHNSON (Filed by)
Rapport Therapeutics (Subject)
Form SC 13G
08/08/2024
6:40 AM
Rapport Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:20 AM
Rapport Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RAPP) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners